Shellback Capital’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VKTX
Shellback Capital's VKTX Position: Q3 2026 in Review
Shellback Capital opened a new position in Viking Therapeutics (VKTX) in Q3 2026: 525,294 shares worth $17.1M. The stake represents 3.03% of the portfolio and ranks #9 among its holdings.
443 funds tracked by Wall St. Rank hold VKTX as of Q3 2026.
- Shellback Capital held 525,294 shares of Viking Therapeutics worth $17.1M as of Q3 2026.
- Viking Therapeutics was a new Shellback Capital position in Q3 2026.
- Viking Therapeutics made up 3.03% of Shellback Capital's portfolio in Q3 2026, its #9 holding.
- 443 funds tracked by Wall St. Rank held Viking Therapeutics as of Q3 2026.
Based on Shellback Capital's 13F filing for Q3 2026, filed 16 Nov 2026.